Signaling Pathways
-
BA2247 PC786Summary: PC786 is an inhaled respiratory syncytial virus L protein polymerase inhibitor. - BA2248 RSV604Summary: RSV604 (A-60444) is an inhibitor of respiratory syncytial virus replication.
- BA2249 AVG-233Summary: AVG-233 is an orally effective RNA-dependent RNA polymerase inhibitor.
- BA2250 ClesrovimabSummary: Clesrovimab (MK1654) is a fully human anti-fusion (RSVF) glycoprotein monoclonal antibody.
- BA2251 EnzaplatovirSummary: Enzaplatovir (BTA-C585) is an orally effective fusion inhibitor.
- BA2252 BMS-433771Summary: BMS-433771 is a potent respiratory syncytial virus (RSV) inhibitor with oral activity.
- BA2254 RSV-IN-1Summary: RSV-IN-1 is an inhibitor of human respiratory syncytial virus.
-
BA2256 PaquinimodSummary: Paquinimod (ABR215757) is a specific inhibitor with oral activity. - BA2257 GSK3326595Summary: GSK3326595 is a protein arginine methyltransferase 5 inhibitor.
- BA2258 ZotatifinSummary: Zotatifin (eFT226) is a potent, selective and well-tolerated eIF4A inhibitor.